Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

mRNAs half-lives determination

ND Ning Dai

Last updated date: Feb 16, 2021 Views: 861 Forks: 0

original An abbreviated version of this protocol was published in eLife in Jul, 2017
IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

Proliferating cells were treated with 1 uM Actinomycin D (Sigma) for 12 hr to block transcription. After desired timepoints, the total RNAs were extracted (Qiagen RNeasy kit), followed by DNase digestion (eliminating DNA contamination) and cDNA syntheses using Oligo-dT primers (Qiagen) . The concentration of specific mRNAs were quantified by Real-Time RT-PCR using the SYBR Green.

Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Dai, N(2021). mRNAs half-lives determination. Bio-protocol Preprint. bio-protocol.org/prep846.
  2. Dai, N., Ji, F., Wright, J., Minichiello, L., Sadreyev, R. and Avruch, J.(2017). IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1. eLife. DOI: 10.7554/eLife.27155

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.